Mulligan Seamus 4
4 · Jazz Pharmaceuticals plc · Filed May 27, 2020
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Purchase
Ordinary Shares
2020-05-26$110.65/sh+15,000$1,659,747→ 1,117,788 total - Purchase
Ordinary Shares
2020-05-27$110.52/sh+8,391$927,352→ 1,131,422 total - Purchase
Ordinary Shares
2020-05-27$112.32/sh+11,482$1,289,646→ 1,152,788 total - Purchase
Ordinary Shares
2020-05-27$109.55/sh+5,243$574,379→ 1,123,031 total - Purchase
Ordinary Shares
2020-05-27$111.56/sh+9,884$1,102,682→ 1,141,306 total
Footnotes (5)
- [F1]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $110.1800 to $110.9800. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F2]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $109.0300 to $110.0200. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F3]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from 110.0300 to $111.0100. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F4]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $111.0350 to $112.0200. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F5]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $112.0500 to $112.6600. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.